|
| ½Ã°£ |
³»¿ë |
| 08:00-08:45 |
Morning Seminar 1: Case discussion of Generalized Epilepsy ÁÂÀå : °íżº
| Semiology of IGE(15ºÐ) | ¼¿ïÀÇ´ë ȲÈñ |
| Dietary treatment of generalized epilepsy(15ºÐ) | ÀÎÁ¦ÀÇ´ë À¯¼öÁ¤ |
| Callosotomy, VNS, and DBS(15ºÐ) | °¿øÀÇ´ë À̼¿µ |
|
| 08:50-10:20 |
Hot Topic Symposium 1: Monotherapy vs. Polytherapy ÁÂÀå : Çã±Õ
| Introduction(5ºÐ) |
| Importance of monotherapy(25ºÐ) | ¾ÆÁÖÀÇ´ë Çã ±Õ |
| Potential advantage of polytherapy(25ºÐ) | ÇѸ²ÀÇ´ë ¼ÛÈ«±â |
| When to use polytherapy and Strategies of polytherapy(20ºÐ) | ¿¬¼¼ÀÇ´ë Çã°æ |
| Questions and comments(15ºÐ) |
|
| 10:30-11:40 |
Hot Topic Symposium 2: Neurogenesis and cell treatment in epilepsy: Inflammation and Epileptogenesis ÁÂÀå : Ȳ¿ë½Â
| Inflammation and epilepsy: insights from the clinic and experimental evidence(40ºÐ)
Mario Negri Institute Annamaria Vezzani |
| Modulation of epileptogenesis by stem/progenitor cells(30ºÐ) |
¼¿ïÀÇ´ë ÁÖ°Ç |
|
| 11:40-12:00 |
°£ÁúÇùȸ °£Áú¸íΰ³Á¤ °æ°úº¸°í |
| 13:00-14:30 |
Special Interest group 1 (Surgery) : Surgical role in chronic epilepsy ÁÂÀå : È«½Âö, ±èÈﵿ |
Selection of surgical candidates(20ºÐ)
¼º±Õ°ü´ë ¼´ë¿ø |
Expectation of Class I outcome(20ºÐ)
¼¿ïÀÇ´ë ±è½Â±â | |
Expectatins of Class II-III outcome(20ºÐ)
ÀüºÏÀÇ´ë °íÀºÁ¤ |
| Prognosis of callosotomy(20ºÐ)
¿ï»êÀÇ´ë È«¼®È£ |
| Questions and comments (10ºÐ) |
|
Special Interest group 2 (Research) : Animal model of epilepsy ÁÂÀå : Àº¹é¸°, ±è¿µÀÎ
|
Introduction & Pentylenetetrazole(15ºÐ)
°¡Å縯ÀÇ´ë ±è¿µÀÎ |
Kainic acid(15ºÐ)
ÀÎÁ¦ÀÇ´ë ±èµ¿¿í |
| Lithium-Pilocarpine(15ºÐ)
¼¿ïÀÇ´ë ÁÖ°Ç |
Flurothyl(15ºÐ)
°í·ÁÀÇ´ë Àº¹é¸° |
Febrile seizure(15ºÐ)
ÇѸ²ÀÇ´ë °ÅÂõ |
| Questions and comments (15ºÐ) |
|
Special Interest group 3 (Social Issues in Epilepsy) :°£ÁúÀå¾Ö ÁÂÀå : ÀÌ»ó¾Ï |
°£ÁúÀå¾ÖÇöȲ/½ÇÅÂ
½ÅÇö¼÷ ¸ñ»ç´Ô |
°£ÁúÀå¾ÖȯÀÚµéÀÇ º¹Áö
º¸°Çº¹ÁöºÎ º¯¿ëÂù |
°£ÁúÀå¾ÖÆò°¡ ±ÔÁ¤ÀÇ ¹®Á¦Á¡
¼øÃµÇâÀÇ´ë Á¤µÎ½Å |
°£ÁúÀå¾ÖÆò°¡±âÁØ
ÇѾçÀÇ´ë °í¿ë |
|
| 14:40-16:10 |
Plenary Session 1: Frontal lobe epilepsy ÁÂÀå : ÀÌÁ¤±³, ÀÌ»ó°Ç
| Functional anatomy of frontal lobe(30ºÐ) | ¼¿ïÀÇ´ë À̰æ¹Î |
| Electrical stimulation of frontal lobe(15ºÐ) | ¼º±Õ°üÀÇ´ë È«½ÂºÀ |
| SSMA epilepsy(15ºÐ) | ¿ï»êÀÇ´ë ÀÌ»ó¾Ï |
| FLCPS(15ºÐ) | °è¸íÀÇ´ë Á¶¿ë¿ø |
| Surgical treatment of FLE(15ºÐ) | ¼¿ïÀÇ´ë Á¤Ãµ±â |
|
| 16:10-16:20 |
Coffee Break |
| 16:20-17:50 |
GSK Satellite symposium Choice of 1st AED ÁÂÀå Ȳ¿ë½Â, ÀÌ»óµµ
When to start AED (20ºÐ) °¡Å縯ÀÇ´ë ÀÌÀα¸
Lamotrigine as the first AED (20ºÐ) ¿¬¼¼ÀÇ´ë Çã°æ
Behavior and mood in epilepsy (20ºÐ) °æºÏÀÇ´ë ¹Ú¼ºÆÄ
Generic versus brand AED (20ºÐ) °¡ÃµÀÇ´ë ½Åµ¿Áø
Questions and comments (10ºÐ)
|
Janssen Satellite symposium
Consideration in the use of new AED
ÁÂÀå À̺´ÀÎ
Approach to the patients with newly diagnosed epilepsy (30ºÐ)
Prof Privitera M
AEDs in childhood epilepsy (20ºÐ) ¿¬¼¼ÀÇ´ë ±èÈﵿ
AEDs and Quality of life (20ºÐ) ¿ï»êÀÇ´ë ÀÌ»ó¾Ï
Retention rate in the use of AED ÇѸ²ÀÇ´ë ±èÁÖ¿ë
|
|
| 18:00-19:00 |
Poster presentation |